Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Go back to Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
(NASDAQ: VIR) Delayed: 9.57 --0 (-0%)
Previous Close $9.57    52 Week High
Open $9.57    52 Week Low
Day High $9.57    P/E N/A 
Day Low $9.57    EPS
Volume 697